Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07132515) titled 'Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC' on Aug. 10.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
Primary Sponsor: Mansoura University
Condition:
Cirrhosis
HCC - Hepatocellular Carcinoma
Portal Vein Thrombosis
Intervention:
Drug: Enoxaparin, warfarrin, or apixaban
Recruitment Status: Recruiting
Phase: Phase 4
Date of First Enrollment: August 15, 2023
Target Sample Size: 100
Countries of Recruitment:
Egypt
To know more, visit https://clinicaltrials.gov/ct2/show...